<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34948065</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>24</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>09</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Sequestosome 1 Is Part of the Interaction Network of VAPB.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13271</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms222413271</ELocationID><Abstract><AbstractText>VAPB (Vesicle-Associated-membrane Protein-associated protein B) is a tail-anchored membrane protein of the endoplasmic reticulum that can also be detected at the inner nuclear membrane. As a component of many contact sites between the endoplasmic reticulum and other organelles, VAPB is engaged in multiple protein interactions with a plethora of binding partners. A mutant version of VAPB, P56S-VAPB, which results from a single point mutation, is involved in a familial form of amyotrophic lateral sclerosis (ALS8). We performed RAPIDS (rapamycin- and APEX-dependent identification of proteins by SILAC) to identify proteins that interact with or are in close proximity to P56S-VAPB. The mutation abrogates the interaction of VAPB with many known binding partners. Here, we identify Sequestosome 1 (SQSTM1), a well-known autophagic adapter protein, as a major interaction/proximity partner of P56S-VAPB. Remarkably, not only the mutant protein, but also wild-type VAPB interacts with SQSTM1, as shown by proximity ligation assays and co-immunoprecipiation experiments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>James</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7443-929X</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, Faculty of Medicine, GZMB (G&#xf6;ttinger Zentrum f&#xfc;r Molekulare Biowissenschaften), Georg-August-University G&#xf6;ttingen, Humboldtallee 23, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenz</LastName><ForeName>Christof</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bioanalytics Group, Institute of Clinical Chemistry, University Medical Center G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e 40, 37075 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urlaub</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Bioanalytics Group, Institute of Clinical Chemistry, University Medical Center G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e 40, 37075 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kehlenbach</LastName><ForeName>Ralph H</ForeName><Initials>RH</Initials><Identifier Source="ORCID">0000-0003-4920-9916</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology, Faculty of Medicine, GZMB (G&#xf6;ttinger Zentrum f&#xfc;r Molekulare Biowissenschaften), Georg-August-University G&#xf6;ttingen, Humboldtallee 23, 37073 G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SFB 1190 (P07 and Z02)</GrantID><Agency>Deutsche Forschungsgemeinschaft</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C099718">SQSTM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C496748">VAPB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>W36ZG6FT64</RegistryNumber><NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009685" MajorTopicYN="N">Nuclear Envelope</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="Y">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SQSTM1</Keyword><Keyword MajorTopicYN="N">VAPB</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">p62</Keyword><Keyword MajorTopicYN="N">sequestosome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34948065</ArticleId><ArticleId IdType="pmc">PMC8707790</ArticleId><ArticleId IdType="doi">10.3390/ijms222413271</ArticleId><ArticleId IdType="pii">ijms222413271</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cabukusta B., Berlin I., van Elsland D.M., Forkink I., Spits M., de Jong A.W., Akkermans J.J., Wijdeven R.H., Janssen G.M., van Veelen P.A., et al. Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT Motifs. Cell Rep. 2020;33:108475. doi: 10.1016/j.celrep.2020.108475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108475</ArticleId><ArticleId IdType="pubmed">33296653</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mattia T., Wilhelm L.P., Ikhlef S., Wendling C., Spehner D., Nomin&#xe9; Y., Giordano F., Mathelin C., Drin G., Tomasetto C., et al. Identification of MOSPD2, a novel scaffold for endoplasmic reticulum membrane contact sites. EMBO Rep. 2018;19:e45453. doi: 10.15252/embr.201745453.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201745453</ArticleId><ArticleId IdType="pmc">PMC6030701</ArticleId><ArticleId IdType="pubmed">29858488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser S.E., Brickner J.H., Reilein A.R., Fenn T.D., Walter P., Brunger A.T. Structural Basis of FFAT Motif-Mediated ER Targeting. Structure. 2005;13:1035&#x2013;1045. doi: 10.1016/j.str.2005.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2005.04.010</ArticleId><ArticleId IdType="pubmed">16004875</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpy F., Rousseau A., Schwab Y., Legueux F., Stoll I., Wendling C., Spiegelhalter C., Kessler P., Mathelin C., Rio M.-C., et al. STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER. J. Cell Sci. 2013;126:5500&#x2013;5512. doi: 10.1242/jcs.139295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.139295</ArticleId><ArticleId IdType="pubmed">24105263</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarilio R., Ramachandran S., Sabanay H., Lev S. Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein Interaction. J. Biol. Chem. 2005;280:5934&#x2013;5944. doi: 10.1074/jbc.M409566200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M409566200</ArticleId><ArticleId IdType="pubmed">15545272</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos K.J., M&#xf3;rotz G.M., Stoica R., Tudor E.L., Lau K.-F., Ackerley S., Warley A., Shaw C.E., Miller C.C.J. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet. 2012;21:1299&#x2013;1311. doi: 10.1093/hmg/ddr559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr559</ArticleId><ArticleId IdType="pmc">PMC3284118</ArticleId><ArticleId IdType="pubmed">22131369</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewen C.J.R., Levine T. A Highly Conserved Binding Site in Vesicle-associated Membrane Protein-associated Protein (VAP) for the FFAT Motif of Lipid-binding Proteins. J. Biol. Chem. 2005;280:14097&#x2013;14104. doi: 10.1074/jbc.M500147200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500147200</ArticleId><ArticleId IdType="pubmed">15668246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyles J.P., McMaster C.R., Ridgway N. Vesicle-associated Membrane Protein-associated Protein-A (VAP-A) Interacts with the Oxysterol-binding Protein to Modify Export from the Endoplasmic Reticulum. J. Biol. Chem. 2002;277:29908&#x2013;29918. doi: 10.1074/jbc.M201191200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M201191200</ArticleId><ArticleId IdType="pubmed">12023275</ArticleId></ArticleIdList></Reference><Reference><Citation>James C., Kehlenbach R. The Interactome of the VAP Family of Proteins: An Overview. Cells. 2021;10:1780. doi: 10.3390/cells10071780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071780</ArticleId><ArticleId IdType="pmc">PMC8306308</ArticleId><ArticleId IdType="pubmed">34359948</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasana E., Fossati M., Ruggiano A., Brambillasca S., Hoogenraad C.C., Navone F., Francolini M., Borgese N. A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum. FASEB J. 2010;24:1419&#x2013;1430. doi: 10.1096/fj.09-147850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-147850</ArticleId><ArticleId IdType="pubmed">20008544</ArticleId></ArticleIdList></Reference><Reference><Citation>James C., M&#xfc;ller M., Goldberg M.W., Lenz C., Urlaub H., Kehlenbach R.H. Proteomic mapping by rapamycin-dependent targeting of APEX2 identifies binding partners of VAPB at the inner nuclear membrane. J. Biol. Chem. 2019;294:16241&#x2013;16254. doi: 10.1074/jbc.RA118.007283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007283</ArticleId><ArticleId IdType="pmc">PMC6827323</ArticleId><ArticleId IdType="pubmed">31519755</ArticleId></ArticleIdList></Reference><Reference><Citation>Saiz-Ros N., Czapiewski R., Epifano I., Stevenson A., Swanson S.K., Dixon C.R., Zamora D.B., McElwee M., Vijayakrishnan S., Richardson C.A., et al. Host Vesicle Fusion Protein VAPB Contributes to the Nuclear Egress Stage of Herpes Simplex Virus Type-1 (HSV-1) Replication. Cells. 2019;8:120. doi: 10.3390/cells8020120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8020120</ArticleId><ArticleId IdType="pmc">PMC6406291</ArticleId><ArticleId IdType="pubmed">30717447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Leal S.S., Benhalevy D., Gomes C.M., Lev S. Structural Requirements for VAP-B Oligomerization and Their Implication in Amyotrophic Lateral Sclerosis-associated VAP-B(P56S) Neurotoxicity. J. Biol. Chem. 2010;285:13839&#x2013;13849. doi: 10.1074/jbc.M109.097345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.097345</ArticleId><ArticleId IdType="pmc">PMC2859547</ArticleId><ArticleId IdType="pubmed">20207736</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., Tunyasuvunakool K., Bates R., &#x17d;&#xed;dek A., Potapenko A., et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583&#x2013;589. doi: 10.1038/s41586-021-03819-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03819-2</ArticleId><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Lua S., Tong J.S., Song J. Elimination of the Native Structure and Solubility of the hVAPB MSP Domain by the Pro56Ser Mutation That Causes Amyotrophic Lateral Sclerosis. Biochemistry. 2010;49:3887&#x2013;3897. doi: 10.1021/bi902057a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi902057a</ArticleId><ArticleId IdType="pubmed">20377183</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttlin E.L., Bruckner R.J., Navarrete-Perea J., Cannon J.R., Baltier K., Gebreab F., Gygi M.P., Thornock A., Zarraga G., Tam S., et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell. 2021;184:3022&#x2013;3040.e28. doi: 10.1016/j.cell.2021.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8165030</ArticleId><ArticleId IdType="pubmed">33961781</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttlin E., Ting L., Bruckner R.J., Gebreab F., Gygi M.P., Szpyt J., Tam S., Zarraga G., Colby G., Baltier K., et al. The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015;162:425&#x2013;440. doi: 10.1016/j.cell.2015.06.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.06.043</ArticleId><ArticleId IdType="pmc">PMC4617211</ArticleId><ArticleId IdType="pubmed">26186194</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustaqim-Barrette A., Lin Y.Q., Pradhan S., Neely G.G., Bellen H.J., Tsuda H. The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control. Hum. Mol. Genet. 2013;23:1975&#x2013;1989. doi: 10.1093/hmg/ddt594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt594</ArticleId><ArticleId IdType="pmc">PMC3959812</ArticleId><ArticleId IdType="pubmed">24271015</ArticleId></ArticleIdList></Reference><Reference><Citation>Costello J., Castro I.G., Hacker C., Schrader T.A., Metz J., Zeuschner D., Azadi A.S., Godinho L.F., Costina V., Findeisen P., et al. ACBD5 and VAPB mediate membrane associations between peroxisomes and the ER. J. Cell Biol. 2017;216:331&#x2013;342. doi: 10.1083/jcb.201607055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201607055</ArticleId><ArticleId IdType="pmc">PMC5294785</ArticleId><ArticleId IdType="pubmed">28108524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano M., Kumagai K., Nishijima M., Hanada K. Efficient Trafficking of Ceramide from the Endoplasmic Reticulum to the Golgi Apparatus Requires a VAMP-associated Protein-interacting FFAT Motif of CERT. J. Biol. Chem. 2006;281:30279&#x2013;30288. doi: 10.1074/jbc.M605032200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M605032200</ArticleId><ArticleId IdType="pubmed">16895911</ArticleId></ArticleIdList></Reference><Reference><Citation>Skehel P.A., Martin K.C., Kandel E.R., Bartsch D. A VAMP-Binding Protein from Aplysia Required for Neurotransmitter Release. Science. 1995;269:1580&#x2013;1583. doi: 10.1126/science.7667638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7667638</ArticleId><ArticleId IdType="pubmed">7667638</ArticleId></ArticleIdList></Reference><Reference><Citation>Soussan L., Burakov D., Daniels M.P., Toister-Achituv M., Porat A., Yarden Y., Elazar Z. Erg30, a Vap-33&#x2013;Related Protein, Functions in Protein Transport Mediated by Copi Vesicles. J. Cell Biol. 1999;146:301&#x2013;312. doi: 10.1083/jcb.146.2.301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.146.2.301</ArticleId><ArticleId IdType="pmc">PMC2156184</ArticleId><ArticleId IdType="pubmed">10427086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Nishimoto I., Aiso S., Matsuoka M. Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8) J. Biol. Chem. 2006;281:30223&#x2013;30233. doi: 10.1074/jbc.M605049200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M605049200</ArticleId><ArticleId IdType="pubmed">16891305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Suzuki H., Aiso S., Matsuoka M. ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2009;39:81&#x2013;89. doi: 10.1007/s12035-009-8054-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-009-8054-3</ArticleId><ArticleId IdType="pubmed">19184563</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Jr., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:1602. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">29045202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Hatano M., Suzuki N. RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration. Sci. Transl. Med. 2017;9:eaah5436. doi: 10.1126/scitranslmed.aah5436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah5436</ArticleId><ArticleId IdType="pubmed">29118263</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin H., Lim L., Wei Y., Gupta G., Song J. Resolving the paradox for protein aggregation diseases: NMR structure and dynamics of the membrane-embedded P56S-MSP causing ALS imply a common mechanism for aggregation-prone proteins to attack membranes. F1000Research. 2014;2:221. doi: 10.12688/f1000research.2-221.v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.2-221.v2</ArticleId><ArticleId IdType="pmc">PMC4168755</ArticleId><ArticleId IdType="pubmed">25254094</ArticleId></ArticleIdList></Reference><Reference><Citation>Papiani G., Ruggiano A., Fossati M., Raimondi A., Bertoni G., Francolini M., Benfante R., Navone F., Borgese N. Restructured endoplasmic reticulum generated by mutant amyotrophic lateral sclerosis-linked VAPB is cleared by the proteasome. J. Cell Sci. 2012;125:3601&#x2013;3611. doi: 10.1242/jcs.102137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.102137</ArticleId><ArticleId IdType="pubmed">22611258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda H., Han S.M., Yang Y., Tong C., Lin Y.Q., Mohan K., Haueter C., Zoghbi A., Harati Y., Kwan J., et al. The Amyotrophic Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for Eph Receptors. Cell. 2008;133:963&#x2013;977. doi: 10.1016/j.cell.2008.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.04.039</ArticleId><ArticleId IdType="pmc">PMC2494862</ArticleId><ArticleId IdType="pubmed">18555774</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgese N., Iacomino N., Colombo S., Navone F. The Link between VAPB Loss of Function and Amyotrophic Lateral Sclerosis. Cells. 2021;10:1865. doi: 10.3390/cells10081865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081865</ArticleId><ArticleId IdType="pmc">PMC8392409</ArticleId><ArticleId IdType="pubmed">34440634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua R., Cheng D., Coyaud E., Freeman S., Di Pietro E., Wang Y., Vissa A., Yip C.M., Fairn G.D., Braverman N., et al. VAPs and ACBD5 tether peroxisomes to the ER for peroxisome maintenance and lipid homeostasis. J. Cell Biol. 2017;216:367&#x2013;377. doi: 10.1083/jcb.201608128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201608128</ArticleId><ArticleId IdType="pmc">PMC5294787</ArticleId><ArticleId IdType="pubmed">28108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Silbernagel N., Walecki M., Sch&#xe4;fer M.K., Kessler M., Zobeiri M., Rinn&#xe9; S., Kiper A.K., Komadowski M.A., Vowinkel K.S., Wemh&#xf6;ner K., et al. The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function. FASEB J. 2018;32:6159&#x2013;6173. doi: 10.1096/fj.201800246R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201800246R</ArticleId><ArticleId IdType="pmc">PMC6629115</ArticleId><ArticleId IdType="pubmed">29879376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijpers M., Yu K.L., Teuling E., Akhmanova A., Jaarsma D., Hoogenraad C.C. The ALS8 protein VAPB interacts with the ER&#x2014;Golgi recycling protein YIF1A and regulates membrane delivery into dendrites. EMBO J. 2013;32:2056&#x2013;2072. doi: 10.1038/emboj.2013.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.131</ArticleId><ArticleId IdType="pmc">PMC3715857</ArticleId><ArticleId IdType="pubmed">23736259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Guo H., Dreser A., Yamoah A., Sechi A., Jesse C.M., Katona I., Doukas P., Nikolin S., Ernst S., et al. Pathomechanisms of ALS8: Altered autophagy and defective RNA binding protein (RBP) homeostasis due to the VAPB P56S mutation. Cell Death Dis. 2021;12:466. doi: 10.1038/s41419-021-03710-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03710-y</ArticleId><ArticleId IdType="pmc">PMC8110809</ArticleId><ArticleId IdType="pubmed">33972508</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D., Chalhoub A., Schooley A., Zhang W., Ngsee J.K. A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect. J. Cell Sci. 2012;125:2831&#x2013;2836. doi: 10.1242/jcs.102111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.102111</ArticleId><ArticleId IdType="pubmed">22454507</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuling E., Ahmed S., Haasdijk E., Demmers J., Steinmetz M.O., Akhmanova A., Jaarsma D., Hoogenraad C.C. Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates. J. Neurosci. 2007;27:9801&#x2013;9815. doi: 10.1523/JNEUROSCI.2661-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2661-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672975</ArticleId><ArticleId IdType="pubmed">17804640</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller M., James C., Lenz C., Urlaub H., Kehlenbach R.H. Probing the Environment of Emerin by Enhanced Ascorbate Peroxidase 2 (APEX2)-Mediated Proximity Labeling. Cells. 2020;9:605. doi: 10.3390/cells9030605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9030605</ArticleId><ArticleId IdType="pmc">PMC7140434</ArticleId><ArticleId IdType="pubmed">32138363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Zheng X.F., Brown E.J., Schreiber S.L. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc. Natl. Acad. Sci. USA. 1995;92:4947&#x2013;4951. doi: 10.1073/pnas.92.11.4947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.11.4947</ArticleId><ArticleId IdType="pmc">PMC41824</ArticleId><ArticleId IdType="pubmed">7539137</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobingier B.T., H&#xfc;ttenhain R., Eichel K., Miller K.B., Ting A.Y., von Zastrow M., Krogan N.J. An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells. Cell. 2017;169:350&#x2013;360.e12. doi: 10.1016/j.cell.2017.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.03.022</ArticleId><ArticleId IdType="pmc">PMC5616215</ArticleId><ArticleId IdType="pubmed">28388416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee H.-W., Zou P., Udeshi N.D., Martell J.D., Mootha V.K., Carr S.A., Ting A.Y. Proteomic Mapping of Mitochondria in Living Cells via Spatially Restricted Enzymatic Tagging. Science. 2013;339:1328&#x2013;1331. doi: 10.1126/science.1230593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1230593</ArticleId><ArticleId IdType="pmc">PMC3916822</ArticleId><ArticleId IdType="pubmed">23371551</ArticleId></ArticleIdList></Reference><Reference><Citation>Joung I., Strominger J.L., Shin J. Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc. Natl. Acad. Sci. USA. 1996;93:5991&#x2013;5995. doi: 10.1073/pnas.93.12.5991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.12.5991</ArticleId><ArticleId IdType="pmc">PMC39176</ArticleId><ArticleId IdType="pubmed">8650207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadlamudi R.K., Joung I., Strominger J.L., Shin J. p62, a Phosphotyrosine-independent Ligand of the SH2 Domain of p56lck, Belongs to a New Class of Ubiquitin-binding Proteins. J. Biol. Chem. 1996;271:20235&#x2013;20237. doi: 10.1074/jbc.271.34.20235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.34.20235</ArticleId><ArticleId IdType="pubmed">8702753</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakar K., Karaca S., Port S.A., Urlaub H., Kehlenbach R.H. Identification of CRM1-dependent Nuclear Export Cargos Using Quantitative Mass Spectrometry. Mol. Cell. Proteom. 2013;12:664&#x2013;678. doi: 10.1074/mcp.M112.024877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M112.024877</ArticleId><ArticleId IdType="pmc">PMC3591659</ArticleId><ArticleId IdType="pubmed">23242554</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S., Lamark T., Bruun J.-A., Overvatn A., Bjorkoy G., Johansen T. Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies. J. Biol. Chem. 2010;285:5941&#x2013;5953. doi: 10.1074/jbc.M109.039925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.039925</ArticleId><ArticleId IdType="pmc">PMC2820819</ArticleId><ArticleId IdType="pubmed">20018885</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;derberg O., Gullberg M., Jarvius M., Ridderstrale K., Leuchowius K.-J., Jarvius J., Wester K., Hydbring P., Bahram F., Larsson L.-G., et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods. 2006;3:995&#x2013;1000. doi: 10.1038/nmeth947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth947</ArticleId><ArticleId IdType="pubmed">17072308</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay D., Sengupta S. First evidence of pathogenicity of V234I mutation of hVAPB found in Amyotrophic Lateral Sclerosis. Biochem. Biophys. Res. Commun. 2014;448:108&#x2013;113. doi: 10.1016/j.bbrc.2014.04.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.04.102</ArticleId><ArticleId IdType="pubmed">24792378</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-J., Anagnostou G., Chai A., Withers J., Morris A., Adhikaree J., Pennetta G., de Belleroche J.S. Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis. J. Biol. Chem. 2010;285:40266&#x2013;40281. doi: 10.1074/jbc.M110.161398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.161398</ArticleId><ArticleId IdType="pmc">PMC3001007</ArticleId><ArticleId IdType="pubmed">20940299</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M., Koppers M., van Rheenen W., Medic J., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., van den Berg L.H. VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiol. Aging. 2012;33:2950.e1&#x2013;2950.e4. doi: 10.1016/j.neurobiolaging.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.07.004</ArticleId><ArticleId IdType="pubmed">22878164</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Haass C. TDP-43 and FUS: A nuclear affair. Trends Neurosci. 2011;34:339&#x2013;348. doi: 10.1016/j.tins.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2011.05.002</ArticleId><ArticleId IdType="pubmed">21700347</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka T., Nishiyama R., Shimogori T., Nukina N. Proteomics-Based Approach Identifies Altered ER Domain Properties by ALS-Linked VAPB Mutation. Sci. Rep. 2020;10:7610. doi: 10.1038/s41598-020-64517-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64517-z</ArticleId><ArticleId IdType="pmc">PMC7203144</ArticleId><ArticleId IdType="pubmed">32376919</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Takeda T., Lebon V., Boill&#xe9;e S., Doukour&#xe9; B., Bataillon G., Sazdovitch V., Cazeneuve C., Meininger V., LeGuern E., et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: Genetics and neuropathology. Acta Neuropathol. 2013;125:511&#x2013;522. doi: 10.1007/s00401-013-1090-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1090-0</ArticleId><ArticleId IdType="pubmed">23417734</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Mart&#xed;n P., Saito T., Komatsu M. p62/SQSTM 1: &#x2018;Jack of all trades&#x2019; in health and cancer. FEBS J. 2018;286:8&#x2013;23. doi: 10.1111/febs.14712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14712</ArticleId><ArticleId IdType="pmc">PMC7379270</ArticleId><ArticleId IdType="pubmed">30499183</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran A., Amanchy R., Linares J.F., Joshi J., Abu-Baker S., Porollo A., Hansen M., Moscat J., Diaz-Meco M.T. p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway. Mol. Cell. 2011;44:134&#x2013;146. doi: 10.1016/j.molcel.2011.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.06.038</ArticleId><ArticleId IdType="pmc">PMC3190169</ArticleId><ArticleId IdType="pubmed">21981924</ArticleId></ArticleIdList></Reference><Reference><Citation>Larroquette F., Seto L., Gaub P.L., Kamal B., Wallis D., Larivi&#xe8;re R., Vall&#xe9;e J., Robitaille R., Tsuda H. Vapb/Amyotrophic lateral sclerosis 8 knock-in mice display slowly progressive motor behavior defects accompanying ER stress and autophagic response. Hum. Mol. Genet. 2015;24:6515&#x2013;6529. doi: 10.1093/hmg/ddv360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv360</ArticleId><ArticleId IdType="pmc">PMC4614709</ArticleId><ArticleId IdType="pubmed">26362257</ArticleId></ArticleIdList></Reference><Reference><Citation>Turco E., Witt M., Abert C., Bock-Bierbaum T., Su M.-Y., Trapannone R., Sztacho M., Danieli A., Shi X., Zaffagnini G., et al. FIP200 Claw Domain Binding to p62 Promotes Autophagosome Formation at Ubiquitin Condensates. Mol. Cell. 2019;74:330&#x2013;346.e11. doi: 10.1016/j.molcel.2019.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.01.035</ArticleId><ArticleId IdType="pmc">PMC6477179</ArticleId><ArticleId IdType="pubmed">30853400</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.G., Liu N., Miao G., Chen Y., Zhao H., Zhang H. The ER Contact Proteins VAPA/B Interact with Multiple Autophagy Proteins to Modulate Autophagosome Biogenesis. Curr. Biol. 2018;28:1234&#x2013;1245.e4. doi: 10.1016/j.cub.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.03.002</ArticleId><ArticleId IdType="pubmed">29628370</ArticleId></ArticleIdList></Reference><Reference><Citation>Portz B., Lee B.L., Shorter J. FUS and TDP-43 Phases in Health and Disease. Trends Biochem. Sci. 2021;46:550&#x2013;563. doi: 10.1016/j.tibs.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC8195841</ArticleId><ArticleId IdType="pubmed">33446423</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkamp S., Mostafavi S., Sachse C. Structure and function of p62/SQSTM1 in the emerging framework of phase separation. FEBS J. 2020;10:1111. doi: 10.1111/febs.15672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15672</ArticleId><ArticleId IdType="pubmed">33332721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D., Wu R., Zheng J., Li P., Yu L. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018;28:405&#x2013;415. doi: 10.1038/s41422-018-0017-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0017-7</ArticleId><ArticleId IdType="pmc">PMC5939046</ArticleId><ArticleId IdType="pubmed">29507397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Suaga P., Paillusson S., Stoica R., Noble W., Hanger D.P., Miller C.C.J. The ER-Mitochondria Tethering Complex VAPB-PTPIP51 Regulates Autophagy. Curr. Biol. 2017;27:371&#x2013;385. doi: 10.1016/j.cub.2016.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2016.12.038</ArticleId><ArticleId IdType="pmc">PMC5300905</ArticleId><ArticleId IdType="pubmed">28132811</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Hao Z., Ren H., Wang G. Loss of VAPB Regulates Autophagy in a Beclin 1-Dependent Manner. Neurosci. Bull. 2018;34:1037&#x2013;1046. doi: 10.1007/s12264-018-0276-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-018-0276-9</ArticleId><ArticleId IdType="pmc">PMC6246830</ArticleId><ArticleId IdType="pubmed">30143980</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff J., Monroy J.R., Jamieson C., Rajanala K., Vilardi F., Schwappach B., Kehlenbach R.H. Emery-Dreifuss muscular dystrophy mutations impair TRC40-mediated targeting of emerin to the inner nuclear membrane. J. Cell Sci. 2016;129:502&#x2013;516. doi: 10.1242/jcs.179333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.179333</ArticleId><ArticleId IdType="pubmed">26675233</ArticleId></ArticleIdList></Reference><Reference><Citation>Charneau P., Mirambeau G., Roux P., Paulous S., Buc H., Clavel F. HIV-1 Reverse Transcription A Termination Step at the Center of the Genome. J. Mol. Biol. 1994;241:651&#x2013;662. doi: 10.1006/jmbi.1994.1542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1994.1542</ArticleId><ArticleId IdType="pubmed">7520946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 1987;7:2745&#x2013;2752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC367891</ArticleId><ArticleId IdType="pubmed">3670292</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanassov I., Urlaub H. Increased proteome coverage by combining PAGE and peptide isoelectric focusing: Comparative study of gel-based separation approaches. Proteomics. 2013;13:2947&#x2013;2955. doi: 10.1002/pmic.201300035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201300035</ArticleId><ArticleId IdType="pmc">PMC4285200</ArticleId><ArticleId IdType="pubmed">23943586</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367&#x2013;1372. doi: 10.1038/nbt.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizcaino J.A., Deutsch E., Wang R., Csordas A., Reisinger F., Rios D., Dianes J.A., Sun Z., Farrah T., Bandeira N., et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 2014;32:223&#x2013;226. doi: 10.1038/nbt.2839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2839</ArticleId><ArticleId IdType="pmc">PMC3986813</ArticleId><ArticleId IdType="pubmed">24727771</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., Guertin D.A., Chang J.H., Lindquist R.A., Moffat J., et al. CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100. doi: 10.1186/gb-2006-7-10-r100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2006-7-10-r100</ArticleId><ArticleId IdType="pmc">PMC1794559</ArticleId><ArticleId IdType="pubmed">17076895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamentsky L., Jones T.R., Fraser A., Bray M.-A., Logan D.J., Madden K.L., Ljosa V., Rueden C., Eliceiri K.W., Carpenter A.E. Improved structure, function and compatibility for CellProfiler: Modular high-throughput image analysis software. Bioinformatics. 2011;27:1179&#x2013;1180. doi: 10.1093/bioinformatics/btr095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr095</ArticleId><ArticleId IdType="pmc">PMC3072555</ArticleId><ArticleId IdType="pubmed">21349861</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>